Corporate News

Warner Chilcott Bags FDA Approval For New Oral Contraceptive MINASTRINTM

Warner Chilcott plc (WCRX), On Monday revealed that the United States Food and Drug Administration or FDA has approved the company's contaceptive MINASTRINTM 24 FE.

The company in a statement added that the drug was manufactured by a third party and also that it does not expect to be in a position to commercially launch MINASTRIN 24 FE during 2013.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

More Corporate News